Current Report Filing (8-k)
June 14 2018 - 5:20PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date
of earliest event reported): June 14, 2018
STAAR Surgical Company
(Exact Name of Registrant
as Specified in Charter)
Delaware
|
|
0-11634
|
|
95-3797439
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
1911 Walker Ave., Monrovia, California
|
|
91016
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s Telephone Number, Including
Area Code
626-303-7902
Not Applicable
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
¨
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement
communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1 933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
¨
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
¨
|
Item 5.07.
|
Submission of Matters to a Vote of Security Holders
|
The annual meeting of the shareholders of
the Company (the “Annual Meeting”) was held on June 14, 2018. 41,612,465 shares of common stock were outstanding on
the record date for the Annual Meeting (April 16, 2018) and entitled to vote at the Annual Meeting. The voting was as follows:
|
1.
|
To elect five directors to serve for terms to expire in 2019 or until their successors have been elected and qualified.
|
|
|
Number of Shares
|
|
For
|
|
Withheld
|
|
Broker Non-Votes
|
Stephen Farrell
|
|
31,713,145
|
|
399,881
|
|
4,849,874
|
Caren Mason
|
|
31,714,274
|
|
398,752
|
|
4,849,874
|
John Moore
|
|
31,711,224
|
|
401,802
|
|
4,849,874
|
Louis Silverman
|
|
31,945,687
|
|
167,339
|
|
4,849,874
|
William Wall
|
|
31,942,637
|
|
170,389
|
|
4,849,874
|
|
2.
|
To approve the Amended and Restated STAAR Surgical Company Omnibus Equity Incentive Plan.
|
Number of Shares
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
24,963,510
|
|
7,038,291
|
|
111,225
|
|
4,849,874
|
|
3.
|
To adopt amendments to the Amended and Restated Certificate of Incorporation (the “COI”) to make certain changes
reflecting current practices in corporate governance and to make certain ministerial and conforming changes.
|
Number of Shares
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
31,976,217
|
|
25,068
|
|
111,741
|
|
4,849,874
|
|
4.
|
To adopt amendments to the Amended and Restated Bylaws (the “Bylaws”) to make certain changes reflecting current
practices in corporate governance and to make certain ministerial and conforming changes.
|
Number of Shares
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
31,974,692
|
|
24,468
|
|
113,866
|
|
4,849,874
|
|
5.
|
To adopt amendments to the COI to increase the minimum number of authorized directors from three to five.
|
Number of Shares
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
31,616,477
|
|
391,234
|
|
105,315
|
|
4,849,874
|
|
6.
|
To adopt amendments to the Bylaws to increase the minimum number of authorized directors from three to five.
|
Number of Shares
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
31,616,752
|
|
391,234
|
|
105,040
|
|
4,849,874
|
|
7.
|
To adopt amendments to the COI to reflect that directors may be removed with or without cause.
|
Number of Shares
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
31,964,949
|
|
22,531
|
|
125,546
|
|
4,849,874
|
|
8.
|
To adopt amendments to the Bylaws to reflect that directors may be removed with or without cause.
|
Number of Shares
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
31,963,299
|
|
24,531
|
|
125,196
|
|
4,849,874
|
|
9.
|
To ratify the selection of BDO USA, LLP as the Company’s independent registered public accountants for the fiscal year
ending December 28, 2018.
|
Number of Shares
|
|
|
For
|
|
Against
|
|
Abstain
|
|
|
36,808,243
|
|
142,858
|
|
11,799
|
|
|
|
10.
|
To hold an advisory vote to approve STAAR’s annual compensation program from non-employee directors.
|
Number of Shares
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
31,546,370
|
|
458,186
|
|
108,470
|
|
4,849,874
|
|
11.
|
To hold an advisory vote to approve STAAR’s compensation of its named executive officers.
|
Number of Shares
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
31,448,047
|
|
555,409
|
|
109,570
|
|
4,849,874
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
June 14, 2018
|
STAAR Surgical Company
|
|
|
|
|
|
|
|
|
By:
|
/s/ Caren Mason
|
|
|
|
Caren Mason
President and Chief Executive Officer
|
|
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Jun 2024 to Jul 2024
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Jul 2023 to Jul 2024